Literature DB >> 18165348

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

David M Nathan1, John B Buse, Mayer B Davidson, Ele Ferrannini, Rury R Holman, Robert Sherwin, Bernard Zinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18165348     DOI： 10.2337/dc08-9016

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  53 in total

1.  Inflammatory signaling: another drug target to improve glycemic control in type 2 diabetes.

Authors:  Barry J Goldstein
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

2.  [What is happening with the new diabetes mellitus drugs?].

Authors:  Eduard Diogène Fadini; Dolores Rodríguez Cumplido
Journal:  Aten Primaria       Date:  2009-04-26       Impact factor: 1.137

3.  Use of a uniform treatment algorithm abolishes racial disparities in glycemic control.

Authors:  Mary K Rhee; David C Ziemer; Jane Caudle; Paul Kolm; Lawrence S Phillips
Journal:  Diabetes Educ       Date:  2008 Jul-Aug       Impact factor: 2.140

4.  Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.

Authors:  S Shah; M Benroubi; V Borzi; J Gumprecht; R Kawamori; J Shaban; M Shestakova; Y Wenying; P Valensi
Journal:  Int J Clin Pract       Date:  2009-02-05       Impact factor: 2.503

5.  Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes.

Authors:  Magnus Dencker; Martin Stagmo; Mozhgan Dorkhan
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

6.  Protocol and baseline data from The Inala Chronic Disease Management Service evaluation study: a health services intervention study for diabetes care.

Authors:  Deborah A Askew; Claire L Jackson; Robert S Ware; Anthony Russell
Journal:  BMC Health Serv Res       Date:  2010-05-24       Impact factor: 2.655

7.  Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Authors:  Peter Sharplin; Jason Gordon; John R Peters; Anthony P Tetlow; Andrea J Longman; Philip McEwan
Journal:  Cardiovasc Diabetol       Date:  2009-02-16       Impact factor: 9.951

8.  Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study.

Authors:  J Gumprecht; M Benroubi; V Borzi; R Kawamori; J Shaban; S Shah; M Shestakova; Y Wenying; R Ligthelm; P Valensi
Journal:  Int J Clin Pract       Date:  2009-06       Impact factor: 2.503

9.  Incretin-based therapies: new treatments for type 2 diabetes in the new millennium.

Authors:  Joan Khoo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

Review 10.  Changing the treatment paradigm for type 2 diabetes.

Authors:  Stefano Del Prato; Giuseppe Penno; Roberto Miccoli
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.